Drs. Berrocal Reflect on ASRS 2026

• by Audina M. Berrocal, MD, Maria H. Berrocal, MD

• July 15, 2026

ORG Detects Retinal Dysfunction Before Structural Changes

At ASRS 2026, Kareem Moussa, MD, presented early data suggesting optoretinography may identify photoreceptor dysfunction in diabetic eyes before conventional imaging reveals abnormalities.

• by Jim Gallagher, senior managing editor

• July 15, 2026

• 3 min

Alkeus Launches Phase 3 Stargardt Trial

At OIS Retina, Carlos Quezada Ruiz, MD, highlighted the launch of the global phase 3 NORTHSTAR trial evaluating investigational oral gildeuretinol for Stargardt disease.

• by Carlos Quezada Ruiz, MD

• July 15, 2026

• 2 min

A First Look at Phase 2 ArMaDa Data

Arshad M. Khanani, MD, FASRS, discusses phase 2 findings for OCU410, an investigational gene therapy for geographic atrophy. A phase 3 program is expected to begin later this year.

• by Arshad M. Khanani, MD, MA, FASRS

• July 15, 2026

• 2 min